Procaps Group, S.A Receivables 2020-2023 | PROCF
Procaps Group, S.A receivables from 2020 to 2023. Receivables can be defined as the total amount of collectibles for a company
Procaps Group, S.A Annual Receivables (Millions of US $) |
2022 |
$130 |
2021 |
$117 |
2020 |
$96 |
2020 |
$ |
2019 |
$ |
2019 |
$ |
2018 |
$ |
Procaps Group, S.A Quarterly Receivables (Millions of US $) |
2023-09-30 |
$143 |
2023-06-30 |
$137 |
2023-03-31 |
$116 |
2022-12-31 |
$130 |
2022-09-30 |
$129 |
2022-06-30 |
$120 |
2022-03-31 |
$112 |
2021-12-31 |
$117 |
2021-09-30 |
$110 |
2021-06-30 |
|
2021-03-31 |
|
2020-12-31 |
$96 |
2020-09-30 |
|
2020-06-30 |
|
2020-03-31 |
|
2019-12-31 |
|
2019-09-30 |
|
2019-06-30 |
|
2019-03-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-DRUGS |
$0.125B |
$0.410B |
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|